Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
0.4701
-0.0817 (-14.81%)
At close: Jan 8, 2026, 4:00 PM EST
0.4701
0.00 (0.00%)
Pre-market: Jan 9, 2026, 4:23 AM EST
Akanda Market Cap
Akanda has a market cap or net worth of $342.35 thousand as of January 9, 2026. Its market cap has decreased by -82.36% in one year.
Market Cap
342.35K
Enterprise Value
-1.79M
1-Year Change
-82.36%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since the IPO on March 15, 2022, Akanda's market cap has decreased from $303.48M to $342.35K, a decrease of -99.89%. That is a compound annual growth rate of -83.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 401.84K | 20.66% |
| Dec 31, 2025 | 333.02K | -85.41% |
| Dec 31, 2024 | 2.28M | 28.76% |
| Dec 29, 2023 | 1.77M | -63.33% |
| Dec 30, 2022 | 4.83M | -98.41% |
| Mar 15, 2022 | 303.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |